Clinical Trial Detail

NCT ID NCT03070301
Title A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements no
Sponsors Memorial Sloan Kettering Cancer Center

neuroendocrine tumor


Everolimus + Ribociclib

Age Groups: adult senior

No variant requirements are available.